India strengthening its MedTech ecosystem; GST changes energize sector - Medical Buyer

Medical Buyer

India’s pharmaceutical industry is stepping into 2026, marking the beginning of a critical five-year period to build the required ecosystem to establish itself as an innovation hub in its bid to become a USD 500 billion sector by 2047, amid near-term challenges of tariff fluctuations and global trade realignments. The predominantly generic medicines-driven domestic drug industry, which has grown f…

Sign in to read the full article

Create a free account or sign in to access the complete content.

    GST Press